Back to DE D. E. Shaw & Co., Inc.

NVAXNVAX
Showing 8 of 30 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in NOVAVAX INC

D. E. Shaw & Co., Inc. holds 5.7M shares of NVAX (NOVAVAX INC), worth $53.2M as of 2026-Q2. The position was decreased (-26.7% shares). NVAX represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$53.2M

Current Shares

5.7M

Total Value Change

-$21.8M

Total Shares Change

-286,260

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5.7M
-26.7%
$53.2M0.0%$9.42
0
2026-Q1
Increased
7.7M
+28.6%
$62.8M0.0%$9.49
37
2025-Q4
Increased
6M
+40.2%
$40.3M0.0%$6.72
39
2025-Q3
Increased
4.3M
+8.4%
$37.1M0.0%$8.57
32
2025-Q2
Increased
3.9M
+20.9%
$24.8M0.0%$6.37
34
2025-Q1
Decreased
3.3M
-43.7%
$20.9M0.0%$7.00
0
2024-Q4
Decreased
5.8M
-2.5%
$46.6M0.0%$7.93
0
2024-Q3
Decreased
5.9M
-6.1%
$75M0.1%$13.30
0

Other major holders of NVAX: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, RA CAPITAL MANAGEMENT, L.P., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used